Site is Being Upgraded

Lifespan extension therapy:  Monascin, a yellow pigment isolated from Monascus-fermented product,  may increase life span, via up-regulation of its target gene BubR1, 26/March/2018, 6.11 am

Sugar-based anti-ageing and Lifespan extension therapy: D-Tagatose, a natural sweetener, increases CHIP levels, increases monoubiquitylation of insulin receptor (INSR), decreases INSR protein levels and enhances lifespan via down regulation of its target gene, 26/March/2018, 6.00 am
March 26, 2018
Gaseous therapy for Glaucoma: Hydrogen sulfide, a gaseous neurotransmitter, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against glaucoma via down regulation of its target gene, 26/March/2018, 6.19 am
March 26, 2018
Show all

 What they say: Introduction: 

A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July  2014 issue of the journal  “EMBO”, by Prof Sinclair, North BJ, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Lifespan extension therapy:  Monascin, a yellow pigment isolated from Monascus-fermented product,  may increase life span, via up-regulation of its target gene BubR1


From research findings to Therapeutic Opportunity: 

This study suggests, for the first time, that Monascin may function as a longevity promoter.  Monascinby increasing the expression of its target gene, it may: (a) increase the expression of BuBR1; (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (fig. 1).

[easy_payment currency=”USD”]

Figure 1. Monascin may extend  mammalian life span via up regulation of BuBR1 and down regulation of p70 S6 Kinase

Figure 2. The chemical structure of Monascin.  Monascin  functions as a longevity-promoter by increasing the expression of BuBR1 and other longevity-promoting genes.

 

 

 

 

 

 

 

 

Thereby, it may: (1) increase insulin sensitivity; (2) attenuate cognitive impairment; (3) delay diseases of aging; (4) slow down cardiac aging; (5) promote resistance to bone, immune and motor dysfunction; (6) promote tissue rejuvenation; and (7) prolong median life span. Thus, pharmacological formulations encompassing “Monascin or its analogues, either alone or in combination with other drugs,” may be used to extend the lifespan of an individual (fig.2).

 


Details on the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $500#

Undisclosed mechanistic information: How Monascin  increases the expression of BubR1 and extends mammalian life-span

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com

CitationBoominathan, L., Lifespan extension therapy:  Monascin, a yellow pigment isolated from Monascus-fermented product,  may increase life span, via up-regulation of its target gene BubR1, 26/March/2018, 6.11 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

 

Comments are closed.